Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

The Role of Brown Adipose Tissue Dysfunction in the Development of Cardiovascular Disease.

Chen HJ., Meng T., Gao PJ., Ruan CC.

Narrative Review on Cardiovascular Disease, Chronic Inflammation, published in Front Endocrinol (Lausanne) (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Endocrinol (Lausanne) (2021)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
34113316
PMCID
PMC8185286
DOI
10.3389/fendo.2021.652246
Citations
29

Abstract (original English)

Brown adipose tissue (BAT), consisted of brown adipocytes and stromal vascular fraction, which includes endothelial cells, lymphocytes, fibroblasts and stem cells, plays a vital role in regulating cardiovascular health and diseases. As a thermogenic organ, BAT can influence body through strengthening energy expenditure by promoting glucose and lipid metabolism. In addition, BAT is also an endocrine organ which is able to secret adipokines in an autocrine and/or paracrine fashion. BAT plays a protective role in cardiovascular system through attenuating cardiac remodeling and suppressing inflammatory response. In this review, we summarize the advances from the discovery of BAT to the present and provide an overview on the role of BAT dysfunction in cardiovascular diseases.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipokinesAdipose Tissue, BrownAnimalsAnti-Inflammatory AgentsAortic AneurysmAtherosclerosisCardiovascular DiseasesDisease Models, AnimalDisease Progression

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research